— Know what they know.
Not Investment Advice
Also trades as: 0LB2.L (LSE) · $vol 0M

SUPN NASDAQ

Supernus Pharmaceuticals, Inc.
1W: -3.5% 1M: -1.8% 3M: -2.9% YTD: -0.2% 1Y: +48.7% 3Y: +40.4% 5Y: +61.7%
$48.21
-1.17 (-2.37%)
 
Weekly Expected Move ±5.0%
$44 $47 $49 $52 $54
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 43 · $2.8B mcap · 54M float · 1.32% daily turnover · Short 40% of daily vol

📊 Key Metrics

TTM
$777M
Revenue
+16.3% YoY
$-29M
Net Income
-146.9% YoY
$82M
Free Cash Flow
-49.6% YoY
88.7%
Gross Margin
-3.6%
Op. Margin
-1.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-2.8%
ROA-2.1%
ROIC-4.1%

Valuation

P/E-95.8
P/B2.6
EV/EBITDA64.1

Leverage

Debt/Equity0.04
Current Ratio1.90
Interest Cov.0.0x

Quality Scores

Piotroski F4/9
Altman Z5.74
Beneish M-2.47

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms